The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
Priyabrata Pattnaik
Advertisement
Priyabrata Pattnaik is Technical Manager, Biomanufacturing Sciences Network, at Millipore Corp. (Millipore Singapore Pte. Ltd (Singapore). priyabrata_pattnaik@millipore.com Tel: +65 6403 5308 Fax: +65 6403 5322
Articles by Priyabrata Pattnaik
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
4
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
5